Single source drug and delivery device company Consort Medical issued its audited results for the year ended 30 April on Thursday, with underlying revenue rising 5.8% to £311.1m, or 4.4% at constant exchange rates. The London-listed firm said its underlying EBIT was £42.7m, up 6.8% or 5.3% at constant currencies, while profit before tax was 7.3% higher at £38.2m. Adjusted basic earnings per share fell 0.9% to 64.5p. On a statutory basis, profit before tax fell 21% to £17.3m, with basic ...Den vollständigen Artikel lesen ...